DEA Rescheduling Briefs, Hemp Loopholes, and the Push for Federal THC Rules

Send us Fan Mail The hosts discuss developments in the DEA marijuana rescheduling process, noting final briefs were due Monday and the DEA is now arguing marijuana should not remain in Schedule I, acknowledging accepted medical use for pain, anorexia, and chemotherapy-related nausea, and disputing two Schedule I prongs including safety under medical supervision. They describe a waiting period after transcript-verbatim corrections and predict movement before the midterms, arguing HHS scientifi...